Watson Laboratories recalls
FDA enforcement reports naming Watson Laboratories Inc as the recalling firm.
- Recall reports
- 20
- Class I (serious)
- 1
- Most recent report
- Feb 5, 2014
- Feb 5, 2014Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bo…Drug · Watson Laboratories IncFailed Tablet/Capsule Specifications; Product contains broken tablets.Class II
- Jan 15, 2014Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx onlyDrug · Watson Laboratories IncPresence of Foreign Substance; metal particulates were visually observed in the tablets.Class II
- Sep 25, 2013Hydrocodone Bitartrate and Acetaminophen Tablets, 7Drug · Watson Laboratories IncDefective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.Class III
- Jul 31, 2013Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (N…Drug · Watson Laboratories IncSubpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the produc…Class III
- Mar 27, 2013ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3Drug · Watson Laboratories IncFailed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .Class II
- Mar 27, 2013Meprobamate, Tablets USP, 200 mg, 100 tabletsDrug · Watson Laboratories IncFailed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .Class II
- Mar 27, 2013MeprobamateDrug · Watson Laboratories IncFailed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .Class II
- Dec 26, 2012Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0Drug · Watson Laboratories IncImpurities/Degradation Products: Out-of-specification results were obtained for a known impurities.Class III
- Nov 28, 2012Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets p…Drug · Watson Laboratories IncSuperpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.Class I
- Oct 31, 2012Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tabl…Drug · Watson Laboratories IncCross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).Class II
- Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0
- Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0
- Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0
- Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tab…
- Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0
- Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only,…
- Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laborato…
- Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laborat…
- Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laborator…
- Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laborat…
Page 1 of 2